1 Result: VirTra
VirTra Shines with Record-Breaking Revenue, Beam Global Beats Expectations, Eloxx Pharmaceuticals Misses Estimates, Ducommun Launches Public Offering
May 15th, 2023
VirTra, Inc. (Nasdaq: VTSI) achieved remarkable double-digit millions in quarterly revenue for the first time, surpassing expectations with Q1 2023 earnings per share (EPS) of $0.27 compared to the consensus estimate of $0.04. In after-hours tradi. Read more
Load More Content
Member Login